KR20090081178A - Cosmetic composition containing wild flower extracts - Google Patents

Cosmetic composition containing wild flower extracts Download PDF

Info

Publication number
KR20090081178A
KR20090081178A KR1020080007122A KR20080007122A KR20090081178A KR 20090081178 A KR20090081178 A KR 20090081178A KR 1020080007122 A KR1020080007122 A KR 1020080007122A KR 20080007122 A KR20080007122 A KR 20080007122A KR 20090081178 A KR20090081178 A KR 20090081178A
Authority
KR
South Korea
Prior art keywords
extract
extracts
cosmetic composition
skin
hydrangea
Prior art date
Application number
KR1020080007122A
Other languages
Korean (ko)
Other versions
KR100964723B1 (en
Inventor
윤경섭
김미진
임경란
정택규
Original Assignee
주식회사 사임당화장품
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 사임당화장품 filed Critical 주식회사 사임당화장품
Priority to KR1020080007122A priority Critical patent/KR100964723B1/en
Publication of KR20090081178A publication Critical patent/KR20090081178A/en
Application granted granted Critical
Publication of KR100964723B1 publication Critical patent/KR100964723B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

A composition containing wild flower complex extracts is provided to have excellent synergic effect than single extract and cell viability of fibroblast. A cosmetic composition containing an wild flower extracts comprises a Cinquefoil extracts, Elsholtzia splendens extracts, and Hydrangea extracts and Daffodil extracts. The content of Cinquefoil extracts, Elsholtzia splendens extracts, and Hydrangea extracts and Daffodil extracts is each 20 to 40 weight%. The extract is contained in 0.01 to 50 weight% based on the total weight.

Description

야생화 추출물을 함유하는 화장료 조성물{Cosmetic composition containing wild flower extracts}Cosmetic composition containing wild flower extract {Cosmetic composition containing wild flower extracts}

본 발명은 야생화 추출물을 함유하는 것을 특징으로 하는 여러 가지 유용한 효과를 가진 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition having various useful effects, characterized in that it contains a wildflower extract.

지구상 대부분의 생명체는 공기 중의 산소를 호흡하여 산화시켜 얻어지는 에너지를 이용하여 생명을 유지하는데, 이런 산소가 필요한 대사과정에서 불가피하게 세포를 파괴하는 독성물질들이 부산물로 만들어지며 이것을 활성산소라고 한다. 활성산소는 생체 조직을 공격하여 세포를 산화, 손상시키는 주범이며 유해산소라고도 한다. 한편 병원체나 이물질을 제거하기 위한 생체방어 과정에서도 O2 및 H2O2와 같은 활성산소가 대량 발생하며 이들의 강한 살균 작용을 통해서 병원체로부터 인체를 보호하는 작용을 하기도 한다. 활성산소는 세포나 세포소기관에 손상을 초래하기도 하며 생체 내 여러 단백질의 아미노산을 산화시켜 단백질의 기능 저하를 초래한다. 핵산에도 손상을 주는데 핵산 염기의 변형, 핵산 염기의 유리, 결합의 절단, 당의 산화 분해 등을 초래하여 돌연변이나 암의 원인이 되기도 한다.Most life on earth uses energy obtained by breathing and oxidizing oxygen in the air to maintain life. Toxic substances that inevitably destroy cells in the metabolic processes that require oxygen are made as by-products and are called free radicals. Free radicals attack bodily tissues to oxidize and damage cells, and are also called harmful oxygen. On the other hand, a large amount of free radicals such as O 2 and H 2 O 2 also occurs in the biological defense process to remove the pathogen or foreign substances, and also act to protect the human body from the pathogen through their strong sterilization action. Free radicals may cause damage to cells or organelles, and oxidize amino acids of various proteins in vivo, leading to a decrease in protein function. It also damages nucleic acids, resulting in modification of nucleic acid bases, release of nucleic acid bases, cleavage of bonds, and oxidative degradation of sugars, which can cause mutations and cancer.

활성산소는 세포막을 공격하여 리포푸신(lipofuscin)이라는 대사성 쓰레기 물질을 생성할 수 있다. 신체에 리포푸신이 많아지면 '노화반점'이 생기는데 이것은 세포 파괴로 인한 대사성 쓰레기 물질이 많이 생긴 것을 의미한다. 리포푸신은 다시 세포들이 손상을 회복하고 재생하는 능력에 나쁜 영향을 미치는데 DNA/RNA 합성 및 단백질 합성을 방해하고 중요한 화학적 대사과정에 필요한 세포 효소를 파괴한다. 이러한 활성산소에 의한 손상은 출생부터 시작하여 사망할 때까지 지속하는데 젊은 시절에는 신체가 광범위한 회복, 대체기전이 있기 때문에 그 효과가 상대적으로 적다. 그러나 나이가 들면 활성산소에 의한 손상이 많아지고 그 효과가 누적되는 반면 활성산소에 대항하는 항산화 능력은 떨어져서 세포를 노화시킨다.Free radicals can attack cell membranes to produce metabolic waste material called lipofuscin. The increased amount of lipofuscin in the body leads to 'aging spots', which means that a lot of metabolic debris is produced by cell destruction. Lipofuscin, in turn, adversely affects cells' ability to repair and regenerate damage, disrupting DNA / RNA synthesis and protein synthesis and destroying cellular enzymes necessary for important chemical metabolism. The damage caused by free radicals starts from birth until death. In young age, the body has a wide recovery and substitution mechanism, so its effect is relatively small. However, as we age, the damage caused by free radicals increases and their effects accumulate, while the antioxidant capacity against free radicals declines, aging the cells.

또한 나이가 들어감에 따라 피부는 얼룩지고 칙칙해지며, 기미나 주근깨 등의 잡티가 생기게 되어 이를 개선하고자 하는 많은 노력이 있으며, 또 나이가 들어감에 따라 피부가 처지고 주름살이 생기며, 피부가 건조해지는데 노화에 따른 이러한 증상을 개선하고자 하는 많은 노력이 화장료 제조업계에서는 지대한 관심사항으로 대두하고 있으며, 이를 위해 천연물을 이용한 소정 물질의 추출물을 화장료의 성분으로 포함하기 위한 다각적인 노력이 진행되어왔다.In addition, as the skin ages, the skin becomes stained and dull, and blemishes such as blemishes and freckles are produced, and there are many efforts to improve the skin. As the skin ages, the skin sags, wrinkles occur, and the skin dries. Many efforts to improve these symptoms due to aging has emerged as a great concern in the cosmetic manufacturing industry, for which multifaceted efforts have been made to include extracts of certain substances using natural products as ingredients of cosmetics.

따라서 본 발명이 이루고자 하는 기술적 과제는 피부의 노화에 따른 여러 가지 증상을 개선할 수 있는 화장료 조성물을 제공하는 것이다.Therefore, the technical problem to be achieved by the present invention is to provide a cosmetic composition that can improve various symptoms caused by aging of the skin.

보다 구체적으로, 본 발명은 항산화 효과가 탁월하며, 피부의 노화에 따른 여러 가지 문제점을 개선하기 위한 피부미백, 피부주름 개선, 피부보습 등의 효과를 가진 화장료 조성물을 제공하는 것이다.More specifically, the present invention is to provide a cosmetic composition having an excellent antioxidant effect, the effect of skin whitening, wrinkle improvement, skin moisturizing for improving various problems caused by aging of the skin.

상기 기술적 과제를 달성하기 위하여, 본 발명은 양지꽃 추출물, 꽃향유 추출물, 수국 추출물 및 수선화 추출물을 포함하는 것을 특징으로 하는 항산화용, 피부미백용, 피부주름 개선용 또는 보습용 화장료 조성물을 제공한다.In order to achieve the above technical problem, the present invention provides a cosmetic composition for antioxidant, skin whitening, skin wrinkle improvement or moisturizing, characterized in that it comprises a hydrangea extract, flower fragrance extract, hydrangea extract and narcissus extract.

보다 바람직하게, 본 발명은 상기 화장료 조성물에 있어 양지꽃 추출물, 꽃향유 추출물, 수국 추출물 및 수선화 추출물 각각의 함량이 전체 추출물 중량 대비 20 내지 40중량%인 것을 특징으로 하는 화장료 조성물을 제공한다.More preferably, the present invention provides a cosmetic composition, characterized in that the content of each of the yangji extract, flower fragrance extract, hydrangea extract and narcissus extract in the cosmetic composition is 20 to 40% by weight relative to the total extract weight.

이하, 본 발명에 따른 화장료 조성물 및 이의 제조방법에 대해 보다 구체적으로 설명한다.Hereinafter, the cosmetic composition and the preparation method thereof according to the present invention will be described in more detail.

본 발명에 따른 화장료 조성물은 양지꽃 추출물, 꽃향유 추출물, 수국 추출물 및 수선화 추출물을 유효성분으로 포함하며, 이러한 야생화 추출물들을 유효성분으로 포함하는 화장료 조성물은 뛰어난 항산화 효과, 피부미백 효과, 피부주름 개선효과 및 보습효과를 가진다.The cosmetic composition according to the present invention comprises a birch flower extract, flower fragrance extract, hydrangea extract and narcissus extract as an active ingredient, the cosmetic composition comprising these wildflower extracts as an active ingredient has an excellent antioxidant effect, skin whitening effect, skin wrinkle improvement effect And moisturizing effect.

본 발명은 또한 상기 야생화 추출물들을 단독으로 사용할 때보다 혼합하여 사용할 때 화장료로서 유용한 효과인 상기 항산화 효과, 피부미백 효과, 피부주름 개선효과 및 보습효과가 시너지적으로 월등히 증가한다는 놀라운 발견에 기초한다.The present invention is also based on the surprising finding that the antioxidant, skin whitening, wrinkle improvement and moisturizing effects, which are useful as cosmetics when mixed with the wildflower extracts alone, are synergistically increased.

본 발명에 따른 화장료 조성물에 포함되는 추출물들은 양지꽃, 꽃향유, 수국 및 수선화 각각을 추출 용매로 따로따로 추출하여 얻어진 추출물들을 혼합하여 얻을 수도 있으나, 바람직하게는 양지꽃, 꽃향유, 수국 및 수선화 혼합재를 추출 용매로 한꺼번에 추출하여 얻을 수 있다.Extracts included in the cosmetic composition according to the present invention may be obtained by mixing the extracts obtained by separately extracting each of the fern, flower fragrance oil, hydrangea and narcissus as an extraction solvent, preferably the fern, flower fragrance oil, hydrangea and narcissus mixture It can be obtained by extracting all at once with the extraction solvent.

본 발명에 이용된 양지꽃(Potentilla fragarioides)은 장미과(Rosaceae)에 속하는 다년생 초본식물로서 양지에서 잘 자라며, 한국, 일본, 중국에 분포한다. 한방에서는 전초를 치자연(雉子筵)이라 하며, 뿌리를 치자연근이라 하여 보음, 지혈효과를 나타내는 것으로 알려져 있다(원색천연약물대사전, 남산당, 1989, p423). 양지꽃의 전초로부터 (+)-카테킨(catechin), 퀘르세틴(quercitrin), 카페인산(caffeic acid), 이소퀘르시트린(isoquercitrin), 4-ο-카페오일(caffeoyl)-L-트레올산(threonic acid), 퀘르세틴-3-ο-베타-D-글루코피라노실(glucopyranosyl)-베타-D-크실로피라노사이드(xylopyranoside)가 분리되어 보고된 바 있으며, (+)-카테킨의 경우는 항산화 효과가 있는 것으로 알려져 있다(생약학회지, 29, 1998, p79).Yellow flower used in the present invention ( Potentilla fragarioides ) is a perennial herbaceous plant belonging to the Rosaceae family, growing well in the sun, and distributed in Korea, Japan, and China. In oriental medicine, the outpost is called Cheon-na (, 子 筵) and the root is called Cheon-geun, and it is known to have a hemostasis effect (primary natural drug metabolism, Namsandang, 1989, p423). (+)-Catechin, quercitrin, caffeic acid, isoquercitrin, 4-ο-caffeoyl-L-threolic acid , Quercetin-3-ο-beta-D-glucopyranosyl-beta-D-xylopyranoside has been reported separately, and (+)-catechin has an antioxidant effect The Journal of Pharmacognosy, 29, 1998, p79.

본 발명에 이용된 꽃향유(Elsholtzia splendense)는 꿀풀과(Labiatae) 식물로 우리나라를 비롯한 일본, 중국, 시베리아, 몽골 등지의 산에 주로 자생하는 다년생 초본이다. 약 1% 정도의 정유를 함유하고 있어 강한 향기가 나며, 주성분은 엘스콜치아케톤(elscholtziadeton)이고 그밖에 세스퀘테르텐(sesquiterpen)이 함유되어 있다. 한의학에서는 전초를 약초로 사용하며, 생약명으로 향유(香), 야소(野蘇)라 부르며, 거담(去痰)효과 및 이뇨작용, 해열발한작용, 항균작용을 나타내며, 전신부종 등에 효과가 있는 것으로 알려져 있다(농약정보, 15, 한국농약공업협회, 1994, p86; 도설한방의약대사전, 서울, 동도문화사, 1984, p102; 원색한국본초도감 3rd, 교학사, 2000, p21).Flower fragrance oil ( Elsholtzia) used in the present invention splendense) is a perennial plant that grows mainly in the mountains of Japan, China, Siberia, Mongolia and elsewhere, including South Korea to Lamiaceae (Labiatae) plants. It contains about 1% of essential oils and has a strong scent. The main ingredient is elscholtziadeton and other sesquiterpenes. Herbal medicine is used as a herb, herbal medicine is called spice oil (야), Yaso (野 蘇), it has a expectorant effect and diuretic effect, antipyretic effect, antibacterial effect, and is known to be effective in systemic edema. (Pesticide Information, 15, Korea Pesticide Industry Association, 1994, p86; Dosul Oriental Medical Medicinal Dictionary, Seoul, Dongdo Culture History, 1984, p102; Primary Color Book of Korea) 3rd, Kyohaksa, 2000, p21).

본 발명에 이용된 수국(Hydrangea macrophylla)은 범의귀과(Saxifragaceae)에 속하는 관상용 관목으로 꽃 색이 토양에 따라 중성이면 흰색, 산성이면 청색, 알칼리성이면 분홍색으로 변하여 칠면조처럼 변한다고 해서 칠변화라고 하기도 한다. 전초를 팔선화(八仙花)라고 하며 약용으로 하고, 학질, 심열량계(心熱悸), 신낭풍(腎囊風) 및 번조(煩燥)를 치료하는 효과가 알려져 있다. 잎과 꽃에 항말라리아 작용을 하는 알칼로이드가 있으며, 꽃에 루틴(rutin), 뿌리에 다프네틴(daphnetin)과 움벨리페론(umbelliferone), 히드란게놀(hydrangenol), 히드란그산(hydrangenic acid), 루눌라르산(lunularic acid), 잎에는 스킴민(skimmin) 등이 함유되어 있다(한국의 약용식물, 교학사, 2006, p205; 약초의 성분과 이용, 일월서각, 1999, p318). Hydrangea used in the present invention macrophylla ) is an ornamental shrub belonging to the family Saxifragaceae. The color of the flower changes from neutral to white, acidic to blue, and alkaline to pink, depending on the soil. The outpost is called Palangea (八仙 花), medicinal, and the effect of treating the crane, cardiac calorimetry (心 熱 悸), cystic wind (번 風) and swelling (煩燥) is known. Alkaloids have antimalarial effects on leaves and flowers, rutin on flowers, daphnetin and umbelliferone, hydrangenol, hydrangenic acid, Lunurular acid (lunularic acid), the leaves contain skimmin (skimmin), etc. (Korean medicinal plants, Kyohaksa, 2006, p205; Ingredients and use of herbs, January Seokseok, 1999, p318).

본 발명에 이용된 수선화(Narcissus tazetta)는 수선화과(Amaryllidaceae)에 속하는 여러해살이로 꽃은 백색으로 12~3월에 핀다. 열매를 맺지 못하며, 비늘줄기로 번식한다. 지중해 연안을 원산으로, 전국에서 재배하는 귀화 식물이다. 뿌리는 수선근(水仙根)이라고 하며, 소종(消腫), 배농(排膿)의 효능이 있고, 옹종, 창독 및 독사교상을 치료한다. 비늘줄기, 잎과 꽃에는 리코린(lycorine), 갈란타민(galanthamine), 타제틴(tazettine)이 있으며, 꽃에는 나르시신(narcissin)이 있다. 자궁에 대해 강한 흥분작용이 있고, 육종 및 복수암에 대해 항종양 작용과 항바이러스 작용이 있다. 민간에서는 비늘줄기를 짓찧어 곪은데 사용하며, 즙은 눈병에 효과가 있다고 한다(한국의 약용식물, 교학사, 2006, p549; 약초의 성분과 이용, 일월서각, 1999, p817). Narcissus used in the present invention tazetta is a perennial genus belonging to the family Amaryllidaceae, whose flowers bloom in white to December. It does not bear fruit and multiplies with scales. Native to the Mediterranean coast, it is a naturalized plant grown all over the country. Roots are called narcissus root (水仙 根), small species (消腫), drainage (排膿) efficacy, and carbuncles, changsok and poisonous snakes. The scales, leaves and flowers include lycorine, galanthamine and tazettine, and the flowers have narcissin. There is a strong excitatory effect on the uterus, antitumor action and antiviral action on sarcoma and ascites cancer. In the private sector, it is used to crush the scales, and juice is effective for eye diseases (Korean medicinal plants, Kyohaksa, 2006, p549; Medicinal ingredients and uses, January psalm, 1999, p817).

본 발명은 또한 양지꽃, 꽃향유, 수국 및 수선화 추출물을 포함하는 화장료 조성물의 제조방법을 제공한다. 본 발명에 다른 야생화 추출물은 양지꽃, 꽃향유, 수국 및 수선화 혼합재 일정량 또는 양지꽃, 꽃향유, 수국 및 수선화 각각의 일정량에 대하여 정제수; 탄소수 1 내지 4의 저급 알코올인 메탄올, 에탄올, 프로필알코올, 부틸알코올; 다가알코올인 글리세린, 부틸렌글라이콜, 프로필렌글라이콜; 또는 이들은 혼합 용매를 1 내지 20배 부피량을 가하여 추출한 후, 선택적으로 농축 또는 정제 과정을 거쳐 제조할 수 있다. 보다 바람직하게, 전술한 방법과 같이 추출용매를 가하여 화장료 유효성분물질을 추출하되 (a) 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 50 내지 95℃의 온도 조건에서 4 내지 20시간 가열하여 추출하거나, (b) 5 내지 37℃의 온도 조건에서 1 내지 15일간 침적시켜 유효성분을 추출하는 것이 바람직하다.The present invention also provides a method for producing a cosmetic composition comprising a fern, scented oil, hydrangea and narcissus extract. Other wild flower extracts according to the present invention is purified water for a certain amount of yangji flower, flower fragrance oil, hydrangea and narcissus mixed material or a certain amount of yangji flower, flower fragrance oil, hydrangea and narcissus; Methanol, ethanol, propyl alcohol, butyl alcohol, which are lower alcohols having 1 to 4 carbon atoms; Polyhydric alcohols such as glycerin, butylene glycol and propylene glycol; Alternatively, they may be prepared by extracting the mixed solvent by adding 1 to 20 times the volume, and then selectively concentrating or purifying. More preferably, extracting the cosmetic active ingredient by adding an extraction solvent as described above (a) heating for 4 to 20 hours at a temperature of 50 to 95 ℃ in a state that the cooling condenser is installed to prevent the solvent from evaporating It is preferable to extract by dipping, or (b) by dipping for 1 to 15 days at a temperature condition of 5 to 37 ℃.

본 발명에 따른 화장료 조성물에 있어 전술한 화장료로서의 유용한 효과들을 시너지적으로 향상시키기 위하여 양지꽃 추출물, 꽃향유 추출물, 수국 추출물 및 수선화 추출물 각각의 함량은 전체 추출물 중량 대비 20 내지 40중량%인 것이 바람 직하며, 본 발명에 따른 화장료 조성물은 상기 양지꽃, 꽃향유, 수국 및 수선화를 야생화 전체 중량 대비 각각 20 내지 40 중량%씩 포함한 혼합재를 추출하여 획득한 추출물을 유효성분으로 포함하는 것이 더욱 바람직하다.In the cosmetic composition according to the present invention, in order to synergistically improve the useful effects as the cosmetics described above, the content of each of the hydrangea extract, the fragrance oil extract, the hydrangea extract and the narcissus extract is preferably 20 to 40% by weight based on the total extract weight. In addition, the cosmetic composition according to the present invention more preferably comprises an extract obtained by extracting the mixture containing 20 to 40% by weight of each of the yangyang flowers, fragrance oil, hydrangea and narcissus relative to the total weight of wildflowers.

또한 본 발명의 화장료 조성물에 있어 유효성분인 상기 야생화 추출물은 화장료 조성물 전체 중량 대비 0.01 내지 50 중량%가 포함되면 바람직하다. 추출물의 함량이 0.01중량% 미만인 경우에는 본래 목적하는 여러 가지 유용한 효과 즉, 항산화, 피부미백, 피부주름 개선 또는 보습 효과를 충분하게 달성할 수 없어 바람직하지 못하며, 상기 유효성분인 추출물의 함량이 전체 화장료 중량 대비 50중량%를 초과하는 경우에는 화장료의 안정성에 문제를 발생시킬 수 있으며, 이로 인하여 화장료의 외관이나 사용 시 충분한 화장효과를 발현시킬 수 없는 우려가 있다.In addition, the wildflower extract as an active ingredient in the cosmetic composition of the present invention is preferably included in an amount of 0.01 to 50% by weight relative to the total weight of the cosmetic composition. If the content of the extract is less than 0.01% by weight, it is not desirable to achieve a sufficient amount of useful effects, that is, antioxidant, skin whitening, skin wrinkle improvement or moisturizing effect, which are originally desired, and the content of the extract as an active ingredient is total. When it exceeds 50% by weight relative to the weight of the cosmetics may cause a problem in the stability of the cosmetics, and thus there is a concern that the cosmetic appearance or sufficient cosmetic effects may not be expressed when using the cosmetics.

본 발명에 따른 화장료 조성물은 크림류, 팩류, 로션류, 에센스류, 화장수류, 파운데이션류 또는 메이크업베이스류의 제형으로 제조되어 상용화될 수 있으나, 이에 한정되는 것은 아니다.The cosmetic composition according to the present invention may be prepared and commercialized in the formulation of creams, packs, lotions, essences, lotions, foundations or makeup bases, but is not limited thereto.

본 발명에 따른 양지꽃, 꽃향유, 수국 및 수선화를 포함하는 야생화 혼합재로부터 추출용매를 이용하여 얻어진 추출물은 항산화 효과, 피부미백효과, 피부주름 개선효과, 보습 효과 등의 화장료로서 매우 유용한 효과를 나타내었으며, 특히 혼합물로부터 얻어진 혼합추출물은 단독추출물에 비해 우수한 시너지 효과를 보였다. 또한, 본 발명에 따른 추출물은 높은 농도에서도 섬유아세포의 세포 생존력이 우수하였다.The extract obtained from the wildflower mixture containing yangji flower, scented oil, hydrangea and narcissus according to the present invention using the extraction solvent showed a very useful effect as a cosmetic such as antioxidant effect, skin whitening effect, wrinkle improvement effect, moisturizing effect, etc. In particular, the mixed extract obtained from the mixture showed a superior synergistic effect than the single extract. In addition, the extract according to the present invention was excellent in cell viability of the fibroblasts even at high concentrations.

이하, 본 발명을 구체적으로 설명하기 위해 실시예를 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 아래에서 상술하는 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해서 제공되는 것이다.Hereinafter, the present invention will be described in detail with reference to Examples. However, embodiments according to the present invention can be modified in many different forms, the scope of the present invention should not be construed as limited to the embodiments described below. The embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.

<실시예 1 내지 4><Examples 1 to 4>

정선된 수국 250g, 양지꽃 250g, 꽃향유 250g 및 수선화 250g를 각각 정량하여 추출기에 넣은 후, 추출용매(30% 함수 부틸렌글라이콜) 5kg을 가하고, 상온에서 6일간 침적하여 추출한 후, 400메시 여과포로 여과하고 4℃에서 7일간 방치하여 저온 숙성시킨 다음, 0.45 um의 필터로 2차 여과하였다. 이 추출여액을 냉각콘덴서가 달린 증류장치에서 60℃로 감압 농축하였다.250 g of selected hydrangea, 250 g of hydrangea, 250 g of flower fragrance oil, and 250 g of daffodil, respectively, were weighed into an extractor, and 5 kg of an extraction solvent (30% hydrous butylene glycol) was added thereto, followed by immersion at room temperature for 6 days, followed by 400 mesh filter cloth. After filtration and left at 4 ° C. for 7 days to mature at low temperature, it was filtered secondly with a 0.45 um filter. The extract filtrate was concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling capacitor.

<실시예 5><Example 5>

정선된 수국 62.5g, 양지꽃 62.5g, 꽃향유 62.5g 및 수선화 62.5g를 각각 정량하여 추출기에 넣은 후, 추출용매(30% 함수 부틸렌글라이콜) 5kg을 가하고, 상온에서 6일간 침적하여 추출한 후, 400메시 여과포로 여과하고 4℃에서 7일간 방치하여 저온 숙성시킨 다음, 0.45 um의 필터로 2차 여과하였다. 이 추출여액을 냉각콘 덴서가 달린 증류장치에서 60℃로 감압 농축하였다.After weighing 62.5g of selected hydrangea, 62.5g of hydrangea flower, 62.5g of flower fragrance oil and 62.5g of narcissus, put it in the extractor, add 5kg of extraction solvent (30% hydrous butylene glycol), and extract it by dipping at room temperature for 6 days. After filtration with 400 mesh filter cloth, the mixture was left at 4 ° C. for 7 days to mature at low temperature, followed by secondary filtration with a 0.45 um filter. The extract filtrate was concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling capacitor.

구 분division 추출시료Extraction Sample 실시예 1Example 1 양지꽃Sunny flower 실시예 2Example 2 꽃향유Flower fragrance 실시예 3Example 3 수국hydrangea 실시예 4Example 4 수선화daffodil 실시예 5Example 5 양지꽃, 수국, 꽃향유, 수선화Sunny day, hydrangea, balm, narcissus

<실험예 1> 항산화 효과의 평가Experimental Example 1 Evaluation of Antioxidant Effect

본 발명에 따른 화장료의 유효성분 물질이 갖는 항산화 효과를 알아보기 위하여 자유라디칼 소거활성 실험을 행하였다. 자유라디칼 소거활성 실험은 Kim 등(Kor. J. Pharmacogn., 24(4), 299~303, 1993)의 방법을 변형한 것으로 안정한 자유라디칼인 DPPH(1,1-diphenyl-2-picryl hydrazyl, Sigma사) 시약을 사용하였다.Free radical scavenging activity was conducted to investigate the antioxidant effect of the active ingredient of the cosmetic according to the present invention. Free radical scavenging activity was modified from the method of Kim et al. (Kor. J. Pharmacogn., 24 (4), 299-303, 1993), and stable free radicals DPDP (1,1-diphenyl-2-picryl hydrazyl, Sigma) reagent was used.

먼저, 0.2 mM DPPH 용액 1 mL에 상기 추출 실시예에 따라 수득된 각각의 시료를 메탄올에 적당한 농도로 희석하여 2 mL 혼합하고, 실온에서 10분간 방치한 후 517 nm에서 흡광도를 측정한다. 한편, 상기 자유라디칼소거시험에서의 대조군은 시료용액 대신 메탄올을 넣어 같은 방법으로 측정하며, DPPH 용액 대신 메탄올을 넣어 실시예 각각에 대한 색 보정값을 얻는 것으로 설정하였다.First, each sample obtained according to the above extraction example is diluted in methanol with 1 mL of 0.2 mM DPPH solution, and mixed in 2 mL of methanol at an appropriate concentration, and the absorbance is measured at 517 nm after being left at room temperature for 10 minutes. On the other hand, the control in the free radical elimination test was set to obtain the color correction value for each of the examples by adding methanol instead of the sample solution, and put methanol instead of the DPPH solution.

하기 수학식 1을 이용하여 자유라디칼소거율을 수치로 계산하여 하기 표 2에 나타내었다. 하기 표 2에서, SC50은 자유라디칼소거율 50%를 달성하기 위해 소요되는 시료의 농도로서 다른 성분물질과 상대적으로 비교할 때 사용하는 수치로서 값이 작을수록 소거율이 높음을 나타낸다.By using the following equation 1 to calculate the free radical removal rate as a numerical value is shown in Table 2 below. In Table 2, SC 50 is the concentration of the sample required to achieve 50% free radical scavenging ratio, which is a numerical value used in comparison with other component substances, and the smaller the value, the higher the scavenging ratio.

활성산소소거실험은 Noro 등(Chem. Pharm. Bull., 31, 3984~3987(1983))의 방법을 변형한 것으로, 활성산소(superoxide anion)소거활성평가는 잔틴/잔틴옥시다제(xanthine/xanthine oxidase)효소반응에 의한 활성산소 발생계를 이용하여 활성산소에 의한 니트로블루 테트라졸리움(nitroblue tetrazolim, NBT)의 산화에 의한 흡광도의 변화를 측정하였다.Free radical scavenging experiment was a modification of the method of Noro et al. (Chem. Pharm. Bull., 31, 3984 ~ 3987 (1983)), and superoxide anion scavenging activity was evaluated by xanthine / xanthine. The change in absorbance due to oxidation of nitroblue tetrazolim (NBT) by active oxygen was measured using an active oxygen generation system by oxidase.

Na2CO3 2.4 mL, 잔틴 0.1 mL, EDTA 0.1 mL, BSA 0.1 mL, NBT 0.1 mL 및 시료 0.1 mL을 넣고 잘 혼합하여 25℃에서 10분간 정치하였다. 잔틴 옥시다제 0.1 mL을 넣고 25℃에서 20분간 반응시킨 후, 6 mM CuCl2를 넣어 반응을 정지시켰다. 광파장 560 nm에서 흡광도를 측정하였다. 한편, 상기 활성산소소거활성시험에서의 대조군은 시료용액 대신 정제수를 넣어 같은 방법으로 측정하며, 잔틴 옥시다제 용액 대신 정제수를 넣어 실시예 각각에 대한 색 보정값을 얻는 것으로 설정하였다.2.4 mL of Na 2 CO 3 , 0.1 mL of xanthine, 0.1 mL of EDTA, 0.1 mL of BSA, 0.1 mL of NBT, and 0.1 mL of sample were added thereto, mixed well, and allowed to stand at 25 ° C. for 10 minutes. After adding 0.1 mL of xanthine oxidase and reacting at 25 ° C. for 20 minutes, 6 mM CuCl 2 was added to stop the reaction. Absorbance was measured at an optical wavelength of 560 nm. Meanwhile, the control group in the active oxygen scavenging activity test was set in the same manner by adding purified water instead of the sample solution, and was added to the purified water instead of xanthine oxidase solution to obtain a color correction value for each example.

하기 수학식 2를 이용하여 활성산소소거율을 수치로 계산하여 하기 표 2에 나타내었다. 하기 표 2에서 IC50은 활성산소소거율 50%를 달성하기 위해 소요되는 시료의 농도로서 다른 성분물질과 상대적으로 비교할 때 사용하는 수치로서 값이 작을수록 소거율이 높음을 나타낸다.By using the following equation (2) to calculate the oxygen free radicals are shown in Table 2 below. In Table 2 below, IC 50 is a concentration of the sample required to achieve 50% of the active oxygen scavenging ratio, which is a value used when comparing with other component substances. The smaller the value, the higher the scavenging ratio.

Figure 112008005694354-PAT00001
Figure 112008005694354-PAT00001

Figure 112008005694354-PAT00002
Figure 112008005694354-PAT00002

구 분division SC50(mg/mL)SC 50 (mg / mL) IC50(mg/mL)IC 50 (mg / mL) 실시예 1Example 1 0.0780.078 0.9400.940 실시예 2Example 2 2.6672.667 10 이상over 10 실시예 3Example 3 0.4220.422 2.4222.422 실시예 4Example 4 4.0944.094 50 이상50 or more 실시예 5Example 5 0.0420.042 0.3830.383

상기 표 2에 나타낸 결과와 같이, 단일 추출물 중 실시예 1을 제외한 실시예 2 내지 4는 항산화력이 좋지 않았다. 반면, 혼합 추출 실시예 5에서는 단일 추출물 실시예들인 실시예 2 내지 4에 비해 자유라디칼 및 활성산소를 소거할 수 있는 항산화력이 월등히 증가하였으며, 실시예 1보다도 항산화력이 약 2배 이상 향상되었다.As shown in Table 2, Examples 2 to 4 except Example 1 of the single extract did not have good antioxidant power. On the other hand, in the mixed extract Example 5, the antioxidant power capable of scavenging free radicals and free radicals was significantly increased compared to Examples 2 to 4, which are the single extract examples, and the antioxidant power was about 2 times higher than that of Example 1. .

<실험예 2> 피부주름의 억제 및 개선 효과 평가Experimental Example 2 Evaluation of Inhibition and Improvement of Skin Wrinkles

본 발명에 따른 화장료의 유효성분물질이 갖는 피부주름의 억제 및 개선 효과 검정하고자 엘라스테이즈저해능시험(Elastase Inhibition Activity Test)을 실시하였다.Elastase Inhibition Activity Test was carried out to test the inhibition and improvement effect of the skin wrinkles of the active ingredient of the cosmetic according to the present invention.

엘라스틴(Elastin)을 분해하는 효소인 엘라스테이즈의 활성을 측정하는 방법으로 엘라스테이즈 기질인 N-Succinyl-(Ala)3 ρ-nitroaniline을 이용하여 ρ-nitroaniline이 분해되면서 생기는 색의 변화를 405 nm의 파장에서 흡광도를 측정함으로써 엘라스테이즈 활성을 측정하는 방법이다. 완충액은 pH 8.0, 0.267 M Trizma-HCl (Sigma), 기질액은 8.8 mM N-Succinyl-(Ala)3 ρ-nitroaniline (Sigma), 효소액은 돼지췌장 엘라스테이즈를 10 ug/mL (Sigma)의 농도로 사용하였다. 완충액 60 uL, 기질액 20 uL과 상기 추출 실시예 1 내지 5로부터 얻은 각각의 시료를 농도별로 정제수에 녹여 100 uL로 한 시료액을 섞은 후, 효소액 20 uL을 넣어 25℃ 항온수조에서 15분간 반응시켜 ρ-nitroaniline의 생성량을 마이크로 플레이트 판독기를 이용하여 파장 405 nm에서 측정하였다. 한편, 상기 엘라스테이즈 활성도를 측정하기 위한 대조군은 시료용액 대신 정제수를 넣어 같은 방법으로 측정하였으며, 효소액 대신 정제수를 넣어 각각에 대한 색 보정값을 얻은 경우를 설정하였다.A method for measuring the activity of elastine, an enzyme that degrades elastin, was used to determine the color change caused by the degradation of ρ-nitroaniline using N-Succinyl- (Ala) 3 ρ-nitroaniline, an elastay substrate. It is a method of measuring elastase activity by measuring absorbance at a wavelength of nm. PH 8.0, 0.267 M Trizma-HCl (Sigma), substrate solution 8.8 mM N-Succinyl- (Ala) 3 ρ-nitroaniline (Sigma), enzyme solution 10 ug / mL (Sigma) Used as a concentration. 60 uL of buffer solution, 20 uL of substrate solution and each sample obtained from the extraction examples 1 to 5 were dissolved in purified water for each concentration, and then mixed with 100 uL of sample solution. The amount of p-nitroaniline produced was measured at a wavelength of 405 nm using a microplate reader. On the other hand, the control for measuring the elastase activity was measured in the same way to put the purified water instead of the sample solution, it was set the case of obtaining a color correction value for each of the purified water instead of the enzyme solution.

하기 수학식 3을 이용하여 엘라스테이즈 저해율을 수치로 계산하여 하기 표 3에 나타내었으며, 하기 표 3에 표기된 수치는 시료 1 mg/mL에 대한 저해율로 나타내었다.Elastase inhibition rate was calculated as a numerical value using Equation 3 shown in Table 3 below, the numerical value shown in Table 3 is expressed as the inhibition rate for the sample 1 mg / mL.

Figure 112008005694354-PAT00003
Figure 112008005694354-PAT00003

구 분division 저해율(%)% Inhibition 실시예 1Example 1 10.39810.398 실시예 2Example 2 2.5812.581 실시예 3Example 3 효과 나타나지 않음No effect 실시예 4Example 4 7.9177.917 실시예 5Example 5 25.80625.806

상기 표 3에 나타낸 결과와 같이, 단독 야생화를 이용한 실시예 1 내지 4는 엘라스테이즈 활성저해시험에서는 우수한 효과가 나타나진 않았으나, 혼합 추출 실시예 5에서는 단일 추출물들에 비해 향상된 엘라스테이즈활성 저해 효과를 보였다.As shown in Table 3, Examples 1 to 4 using the single wildflower did not show an excellent effect in the elastase activity inhibition test, but in the mixed extract Example 5, improved inhibition of the elastase activity compared to single extracts It showed an effect.

<실험예 3> 미백효과 평가Experimental Example 3 Evaluation of Whitening Effect

본 발명에 따른 화장료의 유효성분물질이 갖는 미백효과를 확인하기 위해 타이로시네이즈(tyrosinase)라는 효소의 기능이 억제되는 정도를 보고 미백효과를 판단하였다.In order to confirm the whitening effect of the active ingredient of the cosmetic according to the present invention, the whitening effect was determined by looking at the degree of inhibition of the function of an enzyme called tyrosinase.

타이로시네이즈는 생체 내에서 타이로신(tyrosine)이라는 물질의 산화과정을 촉진하여 멜라닌이 생성되게 도와주는 효소이다. 본 실험예에서는 이 효소의 기능을 억제하여 티로신이 산화되어 멜라닌이라는 흑색의 고분자를 형성하는 것을 억제하는 정도를 측정하는 방법(Pomerantz S. H., J. Biochem., 24:161-168, 1966)을 응용해 미백효과를 판정하였다.Tyrosinase is an enzyme that accelerates the oxidation of tyrosine in vivo and helps melanin production. In this experimental example, the method of inhibiting the function of this enzyme to inhibit the oxidation of tyrosine to form a black polymer called melanin (Pomerantz SH, J. Biochem., 24: 161-168, 1966) was applied. The whitening effect was determined.

각 시료들의 타이로시네이즈에 대한 저해활성은 시료 0.9 mL, 0.1 M 인산완충액(pH 6.8) 1.0 mL 및 1.5 mM L-티로신 용액 1.0 mL을 넣은 후, 37℃에서 10분간 워밍업(warm-up)시켰다. 머시룸 타이로시나제(1,500 units/mL) 0.1 mL를 첨가하여 37℃에서 10분간 반응시킨 후 UV-Vis spectrophotometer를 사용하여 475 nm에서 흡광도를 측정하여 타이로시네이즈에 대한 저해율을 측정하였다. 한편, 상기 타이로시네이즈저해시험을 위한 대조군은 시료액 대신 완충용액을 넣어 같은 방법으로 측정하며, 타이로시네이즈 대신 완충용액 넣어 각각의 색 보정값을 얻은 경우로 설정하였다.Tyrosinase inhibitory activity of each sample was warmed up at 37 ° C for 10 minutes after adding 0.9 mL of sample, 1.0 mL of 0.1 M phosphate buffer (pH 6.8) and 1.0 mL of 1.5 mM L-tyrosine solution. I was. 0.1 mL of mushroom tyrosinase (1,500 units / mL) was added and reacted at 37 ° C. for 10 minutes, and then the absorbance was measured at 475 nm using a UV-Vis spectrophotometer to measure the inhibition rate against tyrosinase. On the other hand, the control group for the tyrosinase inhibitory test was set in the case where a buffer solution was put in place of the sample solution and measured in the same manner, and each color correction value was obtained by putting the buffer solution instead of the tyrosinase.

하기 수학식 4를 이용하여 타이로시네이즈 저해율을 수치로 계산하여 하기 표 4에 나타내었으며, 하기 표 4에 표기된 수치는 시료 1 mg/mL에 대한 저해율로 나타내었다.To calculate the tyrosinase inhibition rate using the following Equation 4 as shown in Table 4, the numerical value shown in Table 4 is shown as the inhibition rate for the sample 1 mg / mL.

Figure 112008005694354-PAT00004
Figure 112008005694354-PAT00004

구 분division 저해율(%)% Inhibition 실시예 1Example 1 27.10327.103 실시예 2Example 2 1.6891.689 실시예 3Example 3 효과 나타나지 않음No effect 실시예 4Example 4 19.20919.209 실시예 5Example 5 34.15034.150

상기 표 4에 나타낸 결과와 같이, 실시예 1을 제외한 단독 추출물 실시예에서는 타이로시네이즈 활성저해 효과가 미미하였다. 그러나 혼합 추출물 실시예 5에서는 단일 추출 실시예들인 실시예 2 내지 4에 비해 매우 향상된 타이로시네이즈 활성저해 효과를 보였으며, 실시예 1보다도 향상된 효과를 나타내어 미백 화장료로서의 유용성을 볼 수 있었다.As shown in Table 4, in the extract example except Example 1, the effect of inhibiting tyrosinase activity was insignificant. However, the mixed extract Example 5 showed a very improved tyrosinase inhibitory effect compared to Examples 2 to 4, which are the single extraction examples, and showed an improved effect than Example 1, showing the usefulness as a whitening cosmetic.

<실험예 4> 안전성 평가Experimental Example 4 Safety Evaluation

본 발명에 따른 유효성분물질들의 화장료로서의 1차 안전성을 검증하고자 정상 사람 섬유아세포(normal human fibroblast)를 배양하여 MTT assay 방법으로 세포 생존력을 실시하였다.In order to verify the primary safety as a cosmetic of the active ingredient according to the present invention, normal human fibroblasts were cultured and cell viability was performed by MTT assay method.

본 실험예에 사용된 정상 사람 섬유아세포는 코씨드바이오팜으로부터 분양받아 사용하였다. 세포를 10% 소혈청을 첨가한 DMEM (Dulbecco's Modified Eagle's Medium)에 1×104 세포의 밀도로 접종하고 하루 동안 5% CO2, 37℃에서 배양시켰다. 추출물 시료를 농도별로 혈청을 함유하지 않은 배지에 희석하여 처리하였다. 1일간 배양 후 세포 염색용 염료인 MTT (3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide)를 처리 후, 4시간 동안 더 배양하였다. 염색결정체를 디메틸설폭시드(dimethy sulfoxide)로 녹여내어 540 nm에서 흡광도를 측정하여 상대 비교하였다. 대조군으로는 추출물 시료를 처리하지 않은 배양액을 사용하였다. 하기 수학식 5를 이용하여 세포의 생존능력을 수치로 계산하고, 추출물 시료를 처리하지 않은 대조군의 세포증식율(%)을 100으로 할 때의 상대적인 세포증식효과를 하기 표 5에 나타내었다.Normal human fibroblasts used in this experiment were used as a pre-sale from Cocoid Biopharm. Cells were inoculated at a density of 1 × 10 4 cells in DMEM (Dulbecco's Modified Eagle's Medium) with 10% bovine serum and incubated at 37% for 5% CO 2 for one day. Extract samples were treated by diluting them in media containing no serum for each concentration. After culturing for 1 day, MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide), a dye for cell staining, was treated and further cultured for 4 hours. The chromosome crystals were dissolved in dimethyl sulfoxide and measured for absorbance at 540 nm for relative comparison. As a control, a culture medium without the extract sample was used. Using the following equation (5) to calculate the cell viability as a number, the relative cell proliferation effect when the cell growth rate (%) of the control group without the extract sample to 100 is shown in Table 5 below.

Figure 112008005694354-PAT00005
Figure 112008005694354-PAT00005

구 분division 세포생존율(%)Cell survival rate (%) 10 ug/mL10 ug / mL 100 ug/mL100 ug / mL 1 mg/mL1 mg / mL 실시예 1Example 1 90.594 ~ 95.25190.594-95.251 96.724 ~ 98.88996.724-98.889 103.182 ~ 105.112103.182 ~ 105.112 실시예 2Example 2 88.455 ~ 89.84188.455-89.841 81.394 ~ 85.35481.394 ~ 85.354 89.477 ~ 101.22189.477-101.221 실시예 3Example 3 84.424 ~ 86.21284.424 to 86.212 82.129 ~ 84.63582.129-84.635 92.090 ~ 95.26492.090 ~ 95.264 실시예 4Example 4 84.099 ~ 85.42184.099 ~ 85.421 96.778 ~ 98.55996.778 to 98.559 115.309 ~ 117.254115.309-117.254 실시예 5Example 5 85.947 ~ 89.64485.947-89.644 90.089 ~ 95.62790.089-95.627 92.643 ~ 95.25992.643 ~ 95.259

상기 표 5에 나타낸 결과와 같이, 실시예 1 내지 5는 1 mg/mL 농도까지 섬유아세포 생존력이 90% 이상으로 나타났으며, 이는 실시예들이 섬유아세포에 대한 안전성이 우수함을 나타낸다.As shown in Table 5, Examples 1 to 5 showed a fibroblast viability of 90% or more up to a concentration of 1 mg / mL, which indicates that the examples have excellent safety against fibroblasts.

<제형예 1><Formulation Example 1>

상기 실시예 5에 따른 화장료의 유효성분물질을 함유한 유연화장수의 성분구성을 하기 표 6과 같이 구성하여 제조하였다. 이때, 성분함량의 단위는 중량%이다. 한편, 하기 표 6의 각 성분 번호로 구별된 성분 중에서, 먼저 성분 1(정제수)에 성분 2와 3을 교반 분산시킨 후, 성분 4 내지 6을 가하고, 성분 8 내지 10을 성분 7에 용해시킨 물질과 성분 11을 차례로 가하여 혼합하는 방식으로 제조하였다. 비교제형예로서는 성분 11을 제외한 나머지 성분 구성이나 그 제조방법은 동일하게 진행하여 제조하였다.The composition of the flexible cosmetics containing the active ingredient material of the cosmetic according to Example 5 was prepared as shown in Table 6 below. At this time, the unit of component content is weight%. On the other hand, among the components identified by each component number in Table 6 below, components 2 and 3 were first dispersed and dispersed in component 1 (purified water), and then components 4 to 6 were added, and components 8 to 10 were dissolved in component 7. And component 11 were added in order to prepare a mixture. As a comparative formulation example, the rest of the component constitution except for component 11 and the preparation method thereof were performed in the same manner.

번호number 성 분ingredient 제형예 1 Formulation Example 1 비교제형예1Comparative Formulation Example 1 1One 정제수Purified water 잔량Remaining amount 잔량Remaining amount 22 카보머Carbomer 0.10.1 0.10.1 33 하이드록시에칠셀루로오스Hydroxyethyl cellulose 0.10.1 0.10.1 44 부틸렌글라이콜Butylene Glycol 2.02.0 2.02.0 55 글리세린glycerin 1.01.0 1.01.0 66 피이지-1500Fiji-1500 0.50.5 0.50.5 77 에탄올ethanol 8.08.0 8.08.0 88 폴리옥시에칠렌경화피마자유Polyoxyethylene Cured Castor Oil 0.20.2 0.20.2 99 트리에탄올아민Triethanolamine 0.10.1 0.10.1 1010 방부제antiseptic 미량a very small amount 미량a very small amount 1111 실시예 5에 따른 화장료의 유효성분물질Active ingredient of the cosmetic according to Example 5 10.010.0 --

<제형예 2><Formulation Example 2>

상기 실시예 5에 따른 화장료의 유효성분물질을 함유한 탄력로션의 성분구성을 하기 표 7과 같이 구성하여 제조하였다. 이때, 성분함량의 단위는 중량%이다. 한편, 하기 표 7의 각 성분 번호로 구별된 성분 중에서, 먼저 성분 1 내지 7을 70℃의 온도에서 가열 용해시킨 다음, 성분 8 내지 11을 성분 12에 용해 분산시켜 70℃로 가열한 것에 유화한다. 이후, 상기 유화한 것을 성분 13으로 중화하고, 56℃의 온도로 냉각한 후, 성분 14를 가하여 교반하고 실온으로 냉각하여 제조하였다.The composition of the elastic lotion containing the active ingredient of the cosmetic according to Example 5 was prepared by configuring as shown in Table 7 below. At this time, the unit of component content is weight%. On the other hand, among the components identified by the component numbers in Table 7 below, components 1 to 7 were first dissolved by heating at a temperature of 70 ° C., and then components 8 to 11 were dissolved and dispersed in component 12, and emulsified in those heated to 70 ° C. . Thereafter, the emulsified product was neutralized with component 13, cooled to a temperature of 56 ° C, and then component 14 was added thereto, stirred, and cooled to room temperature.

번호number 성 분ingredient 제형예 2 Formulation Example 2 비교제형예 2Comparative Formulation Example 2 1One 세테아릴알코올Cetearyl Alcohol 1.01.0 1.01.0 22 글리세릴스테아레이트/피이지-100스테아레이트Glyceryl Stearate / Pig-100stearate 1.01.0 1.01.0 33 폴리소르베이트 60Polysorbate 60 1.01.0 1.01.0 44 소르비탄세스퀴올리에이트Sorbitan sesquioleate 0.30.3 0.30.3 55 세틸옥타노에이트Cetyloctanoate 6.06.0 6.06.0 66 스쿠알란Squalane 4.04.0 4.04.0 77 아프리코드커넬오일Apricot Kernel Oil 4.04.0 4.04.0 88 글리세린glycerin 5.05.0 5.05.0 99 카보머Carbomer 0.10.1 0.10.1 1010 산탄검Xanthan Gum 0.030.03 0.030.03 1111 방부제antiseptic 미량a very small amount 미량a very small amount 1212 정제수Purified water 잔량Remaining amount 잔량Remaining amount 1313 아르기닌Arginine 0.10.1 0.10.1 1414 실시예 5에 따른 화장료의 유효성분물질Active ingredient of the cosmetic according to Example 5 10.010.0 --

<실험예 5> 피부 보습 효과의 평가Experimental Example 5 Evaluation of Skin Moisturizing Effect

본 발명에 따른 화장료의 유효성분물질이 갖는 피부 보습에 대한 임상시험으로 피부수분측정기(Corneometer, Courage + Khazaka, GmbH, Germany)를 이용하여 피부전도도를 측정함으로써 피부 보습력을 평가하였다.The skin moisturizing power was evaluated by measuring the skin conductivity using a skin moisture meter (Corneometer, Courage + Khazaka, GmbH, Germany) as a clinical test for skin moisturizing the active ingredient of the cosmetic according to the present invention.

피부수분측정기에 의한 보습력 측정은 피부표면(예, 각질층)의 수분함량을 정전부하용량 계측법(capacitance measurement)으로 측정하는 장비로 피부표면 수분함량 측정이 이미 국소에 도포된 시료의 영향을 받지 않으며, 탐침센서 접촉부위 아래로 30~40 um 깊이의 일정한 측정레벨을 유지하는 장점이 있다.Moisturizing power measurement by skin moisture meter is a device that measures the moisture content of skin surface (e.g. stratum corneum) by capaccitance measurement method. It has the advantage of maintaining a constant measurement level of 30 ~ 40 um below the probe sensor contact.

피부수분측정은 실내온도 20~25℃, 상대습도 40~55% 로 유지시킨 항온항습 조건에서 피부수분측정기를 이용하여 4명의 피검사자에 대하여 팔 안쪽을 측정부위로 하여 2×2 cm의 면적에 제형예 2를 7.5 uL 적용하여 시간별로 측정하였다. 또한 한 측정부위를 각 5회씩 측정하여 평균값으로 표시하였다. 하기 수학식 6을 이용하여 보습력으로서 피부전도도증가율(%)을 수치로 계산하여 나타내었다. 또한, 시료 도포 전에 피부전도도를 측정하여 기본값으로 하였으며, 대조군은 제형예 및 비교제형예 모두 도포하지 않은 것으로 하였다.Skin moisture measurement was carried out in a 2 × 2 cm area using the skin moisture meter under the constant temperature and humidity conditions maintained at room temperature of 20-25 ° C and relative humidity of 40-55%. 7.5 uL of Example 2 was applied and measured over time. In addition, one measurement site was measured five times each and displayed as an average value. Using the following equation (6), the skin conductivity increase rate (%) as a moisturizing power was calculated by the numerical value. In addition, the skin conductivity was measured and defaulted before application of the sample, and the control group was not applied to both the formulation example and the comparative formulation example.

Figure 112008005694354-PAT00006
Figure 112008005694354-PAT00006

시간 경과 (시간)Time lapse (hours) 피부 보습력 (%)Skin Moisturizing Strength (%) 대조군Control 제형예 2Formulation Example 2 비교제형예 2Comparative Formulation Example 2 00 100100 100100 100100 0.50.5 112 ± 7112 ± 7 161 ± 8161 ± 8 142 ± 5142 ± 5 1.51.5 112 ± 5112 ± 5 127 ± 8127 ± 8 115 ± 4115 ± 4 33 105 ± 6105 ± 6 121 ± 10121 ± 10 112 ± 2112 ± 2 55 99 ± 399 ± 3 109 ± 2109 ± 2 100 ± 3100 ± 3

상기 표 8에서 나타난 바와 같이, 실시예 5를 함유하는 제형예 2를 도포함에 따라, 비교제형예 2에 비해 피부 보습력이 증가하였다.As shown in Table 8, according to the application of Formulation Example 2 containing Example 5, the skin moisturizing power was increased compared to Comparative Formulation Example 2.

<제형예 3><Formulation Example 3>

상기 실시예 5에 따른 화장료의 유효성분물질을 함유한 영양크림의 성분구성을 하기 표 9와 같이 구성하여 제조하였다. 이때, 성분함량의 단위는 중량%이다. 한편, 하기 표 9의 각 성분 번호로 구별된 성분 중에서, 먼저 성분 1 내지 7을 70℃의 온도에서 가열 용해시킨 다음, 성분 9 내지 12를 성분 13에 용해 분산시켜 70℃로 가열한 것에 유화하였다. 이후, 상기 유화한 것을 56℃의 온도로 냉각한 후, 성분 14를 가하여 교반하고 실온으로 냉각하여 제조하였다.The ingredient composition of the nourishing cream containing the active ingredient of the cosmetic according to Example 5 was prepared as shown in Table 9. At this time, the unit of component content is weight%. On the other hand, among the components identified by the component numbers in Table 9 below, components 1 to 7 were first dissolved by heating at a temperature of 70 ° C., and then components 9 to 12 were dissolved and dispersed in component 13 and emulsified in heating to 70 ° C. . Thereafter, the emulsified product was cooled to a temperature of 56 ° C., and then component 14 was added thereto, stirred, and cooled to room temperature.

번호number 성 분ingredient 제형예 3Formulation Example 3 비교제형예 3Comparative Formulation Example 3 1One 세테아릴알코올Cetearyl Alcohol 1.01.0 1.01.0 22 글리세릴스테아레이트/피이지-100스테아레이트Glyceryl Stearate / Pig-100stearate 1.01.0 1.01.0 33 폴리소르베이트 60Polysorbate 60 1.01.0 1.01.0 44 소르비탄세스퀴올리에이트Sorbitan sesquioleate 0.30.3 0.30.3 55 세틸옥타노에이트Cetyloctanoate 6.06.0 6.06.0 66 스쿠알란Squalane 8.08.0 4.04.0 77 아프리코드커넬오일Apricot Kernel Oil 4.04.0 4.04.0 88 디메치콘Dimethicone 2.02.0 2.02.0 99 글리세린glycerin 5.05.0 5.05.0 1010 마그네슘알루미늄실리케이트Magnesium Aluminum Silicate 0.40.4 0.40.4 1111 산탄검Xanthan Gum 0.030.03 0.030.03 1212 방부제antiseptic 미량a very small amount 미량a very small amount 1313 정제수Purified water 잔량Remaining amount 잔량Remaining amount 1414 실시예 5에 따른 화장료의 유효성분물질Active ingredient of the cosmetic according to Example 5 10.010.0 --

<실험예 5>Experimental Example 5

본 발명에 따른 여러 가지 유용한 효과를 갖는 화장료 조성물의 피부 주름개선효과 및 피부자극을 평가하기 위하여, 상기 제형예 3과 제형 비교제형예 3에서 제조된 영양크림을 이용하여 관능시험을 실시하였다.In order to evaluate the skin wrinkle improvement effect and skin irritation of the cosmetic composition having various useful effects according to the present invention, a sensory test was conducted using the nourishing cream prepared in Formulation Example 3 and Comparative Formulation Example 3.

관능시험은 피부의 주름개선효과 항목에 대하여는 제형예 3의 영양크림을 기준으로 비교제형예 3의 영양크림이 나타내는 주름개선효과를 상대적으로 평가하게 하였고, 피부자극에 대한 관능평가는 피부의 가려움, 따가움 및 홍반 등의 현상을 평가하게 하였다. 평가는 매우 우수(5점), 우수(3점), 보통(0점), 나쁨(-3점), 매우 나쁨(-5점)의 오점법 기준에 의거하여 수행하였으며, 그 결과를 하기 표 10에 나타내었다. 하기 표 10에서 피부자극은 피부자극이 없는 정도를 나타낸다.In the sensory test, the anti-wrinkle effect of skin was evaluated based on the nutritional cream of Formulation Example 3, and the anti-wrinkle effect of the nutritional cream of Comparative Formulation Example 3 was evaluated. Symptoms such as stinging and erythema were evaluated. The evaluation was performed based on the five-point method of very good (5 points), good (3 points), moderate (0 points), bad (-3 points), and very bad (-5 points). 10 is shown. In Table 10, skin irritation indicates a degree without skin irritation.

번호number 피부자극Skin irritation 주름개선효과Wrinkle improvement effect 제형예 3Formulation Example 3 비교제형예 3Comparative Formulation Example 3 1One 55 55 55 22 44 55 55 33 55 55 55 44 44 44 44 55 55 55 44 66 55 55 44 77 44 44 44 88 44 44 44 99 55 55 55 1010 55 55 55 1111 44 44 44 1212 55 55 55 1313 44 44 44 1414 55 55 55 1515 44 44 44 1616 55 55 55 1717 44 44 44 1818 44 44 44 1919 55 55 55 2020 44 55 55 평균Average 4.434.43 4.524.52 4.504.50

상기 표 10에 나타난 바와 같이, 본 발명에 따른 제형예 3의 화장료 조성물에 대한 피부자극 평가점수는 4.43점으로 매우 양호하게 평가되어, 비교제형예 3과 마찬가지로 피부자극 정도가 낮아 피부 안전성이 우수함을 확인할 수 있었다.As shown in Table 10, the skin irritation evaluation score of the cosmetic composition of Formulation Example 3 according to the present invention was evaluated very well at 4.43, and the skin irritation degree was low, as in Comparative Formulation Example 3. I could confirm it.

또한, 비교제형예 3 대비 제형예 3의 화장료 조성물이 가진 상대적인 피부의 주름개선효과는 평가점수 4.50점으로 개선 정도가 매우 우수함을 알 수 있었다.In addition, it can be seen that the relative improvement of the wrinkles of the skin of the cosmetic composition of Formulation Example 3 compared to Comparative Formulation Example 3 was 4.50, the degree of improvement is very excellent.

Claims (3)

양지꽃 추출물, 꽃향유 추출물, 수국 추출물 및 수선화 추출물을 포함하는 것을 특징으로 하는 항산화용, 피부미백용, 피부주름 개선용 또는 보습용 화장료 조성물.Antioxidant, skin whitening, skin wrinkle improvement or moisturizing cosmetic composition comprising a birch extract, flower fragrance extract, hydrangea extract and narcissus extract. 제1항에 있어서, 상기 양지꽃 추출물, 꽃향유 추출물, 수국 추출물 및 수선화 추출물 각각의 함량은 전체 추출물 중량 대비 20 내지 40중량%인 것을 특징으로 하는 화장료 조성물.The cosmetic composition according to claim 1, wherein the content of each of the hydrangea extract, the flower fragrance extract, the hydrangea extract and the narcissus extract is 20 to 40% by weight based on the total extract weight. 제1항에 있어서, 상기 추출물은 조성물 전체 중량대비 0.01 내지 50중량%가 포함되는 것을 특징으로 하는 화장료 조성물.According to claim 1, wherein the extract is a cosmetic composition, characterized in that it comprises 0.01 to 50% by weight relative to the total weight of the composition.
KR1020080007122A 2008-01-23 2008-01-23 Cosmetic composition containing wild flower extracts KR100964723B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020080007122A KR100964723B1 (en) 2008-01-23 2008-01-23 Cosmetic composition containing wild flower extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020080007122A KR100964723B1 (en) 2008-01-23 2008-01-23 Cosmetic composition containing wild flower extracts

Publications (2)

Publication Number Publication Date
KR20090081178A true KR20090081178A (en) 2009-07-28
KR100964723B1 KR100964723B1 (en) 2010-06-21

Family

ID=41292191

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020080007122A KR100964723B1 (en) 2008-01-23 2008-01-23 Cosmetic composition containing wild flower extracts

Country Status (1)

Country Link
KR (1) KR100964723B1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101155807B1 (en) * 2009-11-11 2012-06-12 (주)아모레퍼시픽 Cosmetic composition for moisturizing and firming the skin
KR20130046994A (en) * 2011-10-31 2013-05-08 (주)아모레퍼시픽 External composition for skin containing extract of potentilla stolonifera var. quelpaertensis nakai
KR101492074B1 (en) * 2012-12-24 2015-02-12 재단법인 홍천메디칼허브연구소 Compositions containing an extract of hydrangea macrophylla for. otaksa for skin whitening
KR20160051714A (en) * 2016-04-26 2016-05-11 (주)아모레퍼시픽 Composition containing glycoproteins extract from plant
KR20160052515A (en) * 2016-04-26 2016-05-12 (주)아모레퍼시픽 Composition containing glycoproteins extract from plant
JP2016141657A (en) * 2015-02-03 2016-08-08 学校法人近畿大学 Melanogenesis inhibitor obtained from flower part of narcissus tazetta var.chinensis
WO2018080156A1 (en) * 2016-10-25 2018-05-03 한국 한의학 연구원 Composition for preventing, improving or treating cognitive impairment, containing potentilla fragarioides extract as active ingredient
CN109414399A (en) * 2016-06-30 2019-03-01 科丝美诗株式会社 Skin irritatin alleviation comprising hydrangea fermentation material and scytitis alleviate the composition that applies some make up
WO2019088720A1 (en) * 2017-11-06 2019-05-09 (주)아모레퍼시픽 Cosmetic composition comprising hydrangea serrata extract for anti-skin aging and moisturization
WO2019124646A1 (en) * 2017-12-19 2019-06-27 코스맥스바이오 주식회사 Composition for preventing or alleviating ultraviolet-induced skin damage, containing hydragenol as active ingredient
KR102066470B1 (en) * 2018-07-09 2020-01-15 재단법인 남원시화장품산업지원센터 A cosmetic composition having a whitening function containing a mixed extract containing Chamomile flower, Brier flower and Chrysanthemum zawadskii flower extract
KR20200012487A (en) * 2018-07-27 2020-02-05 제주대학교 산학협력단 Cosmetic composition containing Narcissus extract
KR20210024358A (en) * 2019-08-22 2021-03-05 재단법인 남원시화장품산업지원센터 A cosmetic composition for antioxidant and wrinkle improvement containing a mixed extract comprising Sorbus commixta branch, Sorbus commixta fruit, Elsholtzia splendens flower and Taraxacum coreanum flower extract
KR20210091430A (en) * 2020-01-14 2021-07-22 김범수 Cosmetic composition containing natural complex extracts as active ingredient
KR20230010998A (en) * 2021-07-13 2023-01-20 동의대학교 산학협력단 COMPOSITION FOR MOISTURIZING SKIN COMPRISING Potentilla supina L. EXTRACT AS AN ACTIVE INGREDIENT

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102034779B1 (en) 2019-01-07 2019-10-22 충남대학교산학협력단 Cosmetic composition for skin whitening comprising ginsenoside Rh1 and Rg2 and extract of Hydrangea macrophylla

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001220313A (en) * 2000-02-09 2001-08-14 Ichimaru Pharcos Co Ltd Cosmetic composition containing steam distillate of plant
JP2001233725A (en) * 2000-02-23 2001-08-28 Shin Nippon Yakugyou Kk Cosmetic composition containing polyphenol compound derived from oenothera tetraptera
KR100638137B1 (en) * 2005-02-28 2006-10-25 (주)아모레퍼시픽 Cosmetic composition containing the Potentilla fragariodes var? major extracts

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101155807B1 (en) * 2009-11-11 2012-06-12 (주)아모레퍼시픽 Cosmetic composition for moisturizing and firming the skin
KR20130046994A (en) * 2011-10-31 2013-05-08 (주)아모레퍼시픽 External composition for skin containing extract of potentilla stolonifera var. quelpaertensis nakai
KR101492074B1 (en) * 2012-12-24 2015-02-12 재단법인 홍천메디칼허브연구소 Compositions containing an extract of hydrangea macrophylla for. otaksa for skin whitening
JP2016141657A (en) * 2015-02-03 2016-08-08 学校法人近畿大学 Melanogenesis inhibitor obtained from flower part of narcissus tazetta var.chinensis
KR20160051714A (en) * 2016-04-26 2016-05-11 (주)아모레퍼시픽 Composition containing glycoproteins extract from plant
KR20160052515A (en) * 2016-04-26 2016-05-12 (주)아모레퍼시픽 Composition containing glycoproteins extract from plant
CN109414399A (en) * 2016-06-30 2019-03-01 科丝美诗株式会社 Skin irritatin alleviation comprising hydrangea fermentation material and scytitis alleviate the composition that applies some make up
WO2018080156A1 (en) * 2016-10-25 2018-05-03 한국 한의학 연구원 Composition for preventing, improving or treating cognitive impairment, containing potentilla fragarioides extract as active ingredient
WO2019088720A1 (en) * 2017-11-06 2019-05-09 (주)아모레퍼시픽 Cosmetic composition comprising hydrangea serrata extract for anti-skin aging and moisturization
CN111315354A (en) * 2017-11-06 2020-06-19 株式会社爱茉莉太平洋 Cosmetic composition containing hydrangea macrophylla extract for resisting skin aging and keeping moisture
WO2019124646A1 (en) * 2017-12-19 2019-06-27 코스맥스바이오 주식회사 Composition for preventing or alleviating ultraviolet-induced skin damage, containing hydragenol as active ingredient
KR102066470B1 (en) * 2018-07-09 2020-01-15 재단법인 남원시화장품산업지원센터 A cosmetic composition having a whitening function containing a mixed extract containing Chamomile flower, Brier flower and Chrysanthemum zawadskii flower extract
KR20200012487A (en) * 2018-07-27 2020-02-05 제주대학교 산학협력단 Cosmetic composition containing Narcissus extract
KR20210024358A (en) * 2019-08-22 2021-03-05 재단법인 남원시화장품산업지원센터 A cosmetic composition for antioxidant and wrinkle improvement containing a mixed extract comprising Sorbus commixta branch, Sorbus commixta fruit, Elsholtzia splendens flower and Taraxacum coreanum flower extract
KR20210091430A (en) * 2020-01-14 2021-07-22 김범수 Cosmetic composition containing natural complex extracts as active ingredient
KR20230010998A (en) * 2021-07-13 2023-01-20 동의대학교 산학협력단 COMPOSITION FOR MOISTURIZING SKIN COMPRISING Potentilla supina L. EXTRACT AS AN ACTIVE INGREDIENT

Also Published As

Publication number Publication date
KR100964723B1 (en) 2010-06-21

Similar Documents

Publication Publication Date Title
KR100964723B1 (en) Cosmetic composition containing wild flower extracts
KR101176529B1 (en) Cosmetic Composition Comprising the extract of Dendropanax morbifera as Active Ingredient
KR101229748B1 (en) Cosmetic compositions containing fermented extract of Hippophae rhamnoides L
KR20210004672A (en) External composition including high pressure homogenizing extract of plant and manufacturing method for the same
KR101574558B1 (en) Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts
KR100994987B1 (en) Cosmetic composition with the calming effect for skins
KR20030064059A (en) Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect
KR20120140141A (en) Cosmetic composition comprising the fermented extracts and the extracts of the rice
KR101930264B1 (en) Cosmetic composition for inhibiting secretion of sebum and for improving acne symptoms containing natural complex extract
KR20200104158A (en) Cosmetic composition comprising centella asiatica extracts cultivated by aquaponics
KR100820237B1 (en) A cosmetic composition comprising an extract of crude drug complex showing anti-oxidant and moisturizing activities
KR20130079220A (en) Skin external composition containing extract of soybean root
KR101370990B1 (en) Anti-heat aging effect of fermented Limonia acidissima extract and its cosmetic usage to improve skin problems
KR20130040316A (en) Cosmetics composites
KR20080049352A (en) Cosmetic composition containing tilianin or acacetin
KR100515418B1 (en) Anti-wrinkle cosmetics composition comprising natural herb extracts
KR100864915B1 (en) Composition comprising mixed extract of japanese apricot and pear blossom having anti-oxidative activity
KR100949390B1 (en) Cosmetics composition containing the extract of the hosta longipes as active ingredient having antioxidant or anti-inflammatory or anti-irritation or moisture effect
KR100981344B1 (en) The cosmetic composition for preventing the skin aging
KR100967018B1 (en) Cosmetic composition comprising a herbal extration
KR20120092229A (en) Cosmetic composition comprising the fermented extracts of tissue cultures of brassica napus l, punica granatum and panax ginseng)
KR20110089793A (en) A cosmetic composition
KR101093901B1 (en) A cosmetic composition comprising an extract of tissue cultured anoectochilus formosanus and a preparation method of the extract of tissue cultured anoectochilus formosanus
KR100670238B1 (en) Skin anti-wrinkle cosmetics composite containing oriental herb extract and manufacturing method thereof
KR101214344B1 (en) Cosmetics composition containing fermented rice bran and licorice extract

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130329

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20140701

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20150610

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20160601

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20170602

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20180604

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20190610

Year of fee payment: 10